We are live on ! Find out more
WINT

Windtree Therapeutics Inc
WINT

Delisted

WINT was delisted on the 4th of May, 2017.

Back to rankings

67 hedge funds and large institutions have $93.5M invested in Windtree Therapeutics Inc in 2014 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 20 increasing their positions, 13 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

79% more call options, than puts

Call options by funds: $828K | Put options by funds: $462K

54% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 13

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

8% less funds holding

Funds holding: 73 → 67 (-6)

20% less capital invested

Capital invested by funds: $117M → $93.5M (-$23.1M)

40% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 15

Holders
67
Holders Change
-6
Holders Change %
-8.22%
% of All Funds
1.92%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
9
Increased
20
Reduced
13
Closed
15
Calls
$828K
Puts
$462K
Net Calls
+$366K
Net Calls Change
+$113K

Top Buyers

Rank Fund Capital Flow
1
TCM
Tamarack Capital Management
California
+$913K
2
Millennium Management
Millennium Management
New York
+$573K
3
PRCM
Pine River Capital Management
Minnesota
+$365K
4
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$269K
5
BIT
BlackRock Institutional Trust
California
+$259K

Top Sellers

Rank Fund Capital Flow
1
Wells Fargo
Wells Fargo
California
-$2.12M
2
GC
Guggenheim Capital
Illinois
-$700K
3
Morgan Stanley
Morgan Stanley
New York
-$585K
4
TI
Turner Investments
Pennsylvania
-$510K
5
TC
TFS Capital
Pennsylvania
-$458K
Name Holding Trade Value Shares
Change 		Change in
Stake
Wells Fargo
51
Wells Fargo
California
$18K -$2.12M -82,928 -99%
VKH
52
Virtu KCG Holdings
New York
$18K +$18.6K +729 New
U
53
UBS
Switzerland
$15K -$385K -15,065 -96%
Citadel Advisors
54
Citadel Advisors
Florida
$9K -$32.6K -1,277 -78%
Citigroup
55
Citigroup
New York
$9K -$3.19K -125 -25%
LTFS
56
Ladenburg Thalmann Financial Services
Florida
$5K – – –
TRCT
57
Tower Research Capital (TRC)
New York
$5K +$5.34K +209 New
Manulife (Manufacturers Life Insurance)
58
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$4K – – –
BNP Paribas Financial Markets
59
BNP Paribas Financial Markets
France
$2.06K – – –
BRWM
60
B. Riley Wealth Management
Tennessee
$2K – – –
PNC Financial Services Group
61
PNC Financial Services Group
Pennsylvania
$2K – – –
Bank of America
62
Bank of America
North Carolina
$1K -$7.31K -286 -86%
HCC
63
Hirtle Callaghan & Co
Pennsylvania
$1K – – –
AIG
64
American International Group
New York
$593 – – –
SFM
65
Soros Fund Management
New York
– -$358K -11,886 Closed
PAM
66
Panagora Asset Management
Massachusetts
– -$342K -11,376 Closed
LP
67
LMR Partners
United Kingdom
– -$157K -5,231 Closed
OAM
68
Oxford Asset Management
United Kingdom
– -$149K -4,936 Closed
BCMU
69
BlueCrest Capital Management (UK)
Guernsey
– -$119K -3,957 Closed
FAAS
70
First Allied Advisory Services
California
– -$98K -3,214 Closed
VAM
71
Visium Asset Management
New York
– -$95K -3,134 Closed
BG
72
BlackRock Group
United Kingdom
– -$87K -2,900 Closed
JP Morgan Chase
73
JP Morgan Chase
New York
– -$86K -2,873 Closed
STIA
74
Stone Toro Investment Advisers
New Jersey
– -$80K -2,643 Closed
CAS
75
CTC Alternative Strategies
Illinois
– -$52K -1,729 Closed
1 2
3
4

WINT Hedge Fund Activity: Q2 2014 in Review

67 of the 3,481 institutional investors tracked by Wall St. Rank reported a position in Windtree Therapeutics Inc (WINT) for Q2 2014, worth a combined $93.5M — down 20% from $117M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of WINT and 9 opened new positions — a net loss of 6 holders — while 13 trimmed existing stakes and 20 added.

The largest buyer was Tamarack Capital Management, adding an estimated $913K. The largest seller was Wells Fargo, cutting an estimated $2.12M.

  • 67 institutional investors held Windtree Therapeutics Inc (WINT) as of Q2 2014, down from 73 in Q1 2014.
  • Funds reported $93.5M of Windtree Therapeutics Inc stock for Q2 2014, down 20% quarter-over-quarter.
  • 9 funds opened new Windtree Therapeutics Inc positions in Q2 2014 and 15 closed out, a net change of -6 holders.
  • The largest Windtree Therapeutics Inc buyer in Q2 2014 was Tamarack Capital Management, an estimated $913K added.
  • The largest Windtree Therapeutics Inc seller in Q2 2014 was Wells Fargo, an estimated $2.12M sold.

Based on aggregated 13F filings for Q2 2014.